E. Galliera

Unique features of the mode of action of ET-743.

R. Mantovani, M. D’Incalci, E. Erba, 2002, The oncologist.

Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.

M. Broggini, M. D’Incalci, S. Marchini, 2002, Cancer research.

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4

M. Broggini, M. D’Incalci, E. Erba, 2003, Leukemia.

p73α Overexpression Is Associated with Resistance to Treatment with DNA-damaging Agents in a Human Ovarian Cancer Cell Line

F. Vikhanskaya, M. Broggini, S. Marchini, 2001 .

Cancer Cell Line Treatment with DNA-damaging Agents in a Human Ovarian Overexpression Is Associated with Resistance to α p 73 Updated

F. Vikhanskaya, M. Broggini, S. Marchini, 2001 .

P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

F. Vikhanskaya, M. Broggini, S. Marchini, 2001, Cancer research.